Management strategies and prognosis of patients ineligible for transcatheter mitral valve replacement
Authors:
- 10 February 2024
- journal article
- research article
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 64, 1-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Real-World Outcomes of Fourth-Generation Mitral Transcatheter RepairJACC: Cardiovascular Interventions, 2023
- Transcatheter Edge-to-Edge Repair in Patients With Anatomically Complex Degenerative Mitral RegurgitationJACC, 2023
- The Clinical Profile and Natural History of Patients Who Fail Screening for Transcatheter Mitral Valve Replacement: Rationale and Design of the Prospective Multicenter Mitral Valve Screening Survey (MVSS)Cardiovascular Revascularization Medicine, 2022
- Characteristics and outcomes of patients screened for transcatheter mitral valve implantation: 1‐year results from the CHOICE‐MI registryEuropean Journal of Heart Failure, 2022
- Transseptal TMVRJACC: Cardiovascular Interventions, 2022
- Current Status and Future Prospects of Transcatheter Mitral Valve ReplacementJACC, 2021
- Causes and Clinical Outcomes of Patients Who Are Ineligible for Transcatheter Mitral Valve ReplacementJACC: Cardiovascular Interventions, 2019
- Advances in Mitral Valve SurgeryCurrent Treatment Options in Cardiovascular Medicine, 2018
- Prevalence and Outcomes of Unoperated Patients With Severe Symptomatic Mitral Regurgitation and Heart FailureJACC, 2014
- Burden of valvular heart diseases: a population-based studyThe Lancet, 2006